European Biotechnology Directory, 2014-15

European Biotechnology Directory, 2014-15
Author:
Publisher:
Total Pages: 169
Release: 2014
Genre: Biochemical engineering
ISBN: 9781921892462

Download European Biotechnology Directory, 2014-15 Book in PDF, Epub and Kindle

The European Directory of Biotechnology Companies is one of the most comprehensive and accurate Directory of companies and executives in the biotechnology industry that have ever been published. It contains more than 2,000 biotechnology companies and 5,000 executives working in the industry throughout Europe.

International Biotechnology Directory

International Biotechnology Directory
Author: J. Coombs
Publisher: Springer
Total Pages: 665
Release: 2016-01-07
Genre: Science
ISBN: 1349135690

Download International Biotechnology Directory Book in PDF, Epub and Kindle

This directory provides the reader with quick-access to information on more than 8000 companies, research centres and academic institutions involved in new and established technologies. This edition offers more than 600 all-new organization listings, including new listings in Europe.

Country-of-Origin Effect of VC Investment in Biotechnology Companies

Country-of-Origin Effect of VC Investment in Biotechnology Companies
Author: Siah Hwee Ang
Publisher:
Total Pages: 15
Release: 2019
Genre:
ISBN:

Download Country-of-Origin Effect of VC Investment in Biotechnology Companies Book in PDF, Epub and Kindle

Biotechnology companies can access financial and management resources through venture capitalist (VC) firms. An analysis of 1,490 VC investments shows that country-of-origin (CO) of biotech companies has an effect on the participation by VC firms in various biotech subsectors. Specifically, it is found that US biotech companies tend to have higher amount received per VC firm, greater number of VC firms investing in them and greater biotech investment experience of the investing VC firms. Asia-Pacific biotech companies have consistently less VC firms investing in them and these investing VC firms tend to have less biotech investment experience. VC firms with greater biotech investment experience are also investing in European biotech companies more than those from the Americas less US. CO also correlates with outcomes in the four of the six key biotech subsectors studied. These findings suggest a strong CO effect of VC investment in biotech companies.